RobertCharlesSergottMD

PubMed

• OCT-Angiography in AQP4-positive NMOSD: finding subclinical disease using a new tool.
  E Ann Yeh, Gavin Giovannoni, Chris Hawkes, Michael Levy, Jeannette Lechner-Scott, Robert C Sergott> ;Multiple Sclerosis and Related Disorders. 2024 Apr 1
• Instances of ocular findings in transgender patients undergoing hormonal therapy.
  Nieves-Ríos, C., Procopio, R., Lee, D., Edwards, R., Pulido, J., Thornton, S., Dunn, J., Oliver, A., Sergott, R., Moster, M.> ;American Journal of Ophthalmology Case Reports. 2023 Dec 1
• 4 citations
  Safety of Lenadogene Nolparvovec Gene Therapy Over 5 Years in 189 Patients With Leber Hereditary Optic Neuropathy.
  Catherine Vignal-Clermont, Patrick Yu-Wai-Man, Nancy J Newman, Valerio Carelli, Mark L Moster, Valerie Biousse, Prem S Subramanian, An-Guor Wang, Sean P Donahue, Bart ...> ;American Journal of Ophthalmology. 2023 May 1
• 4 citations
  Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G>A MT-ND4 Mut...
  Valerio Carelli, Nancy J Newman, Patrick Yu-Wai-Man, Valerie Biousse, Mark L Moster, Prem S Subramanian, Catherine Vignal-Clermont, An-Guor Wang, Sean P Donahue, Bart ...> ;Ophthalmology and Therapy. 2023 Feb 1
• 13 citations
  Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy.
  Nancy J Newman, Patrick Yu-Wai-Man, Prem S Subramanian, Mark L Moster, An-Guor Wang, Sean P Donahue, Bart P Leroy, Valerio Carelli, Valerie Biousse, Catherine Vignal-C...> ;Brain. 2023 Apr 19
• 2 citations
  Early vigabatrin augmenting GABA-ergic pathways in post-anoxic status epilepticus (VIGAB-STAT) phase IIa clinical trial study protocol.
  Carolina B Maciel, Fernanda J P Teixeira, Katie J Dickinson, Jessica C Spana, Lisa H Merck, Alejandro A Rabinstein, Robert Sergott, Guogen Shan, Guanhong Miao, Charles...> ;Neurological Research and Practice. 2022 Jan 24
• In Reply: Experience With Ventriculoperitoneal and Lumboperitoneal Shunting for the Treatment of Idiopathic Intracranial Hypertension: A Single Institution Series.
  Ahmad Sweid, Badih J Daou, Joshua H Weinberg, Robert M Starke, Robert C Sergott, Joseph Schaefer, Julie Hauge, Caroline Elizabeth, Nohra Chalouhi, M Reid Gooch, Nabeel...> ;Operative Neurosurgery. 2021 Nov 15
• 10 citations
  Gene Therapies for the Treatment of Leber Hereditary Optic Neuropathy.
  José-Alain Sahel, Nancy J. Newman, Patrick Yu-Wai-Man, Catherine Vignal-Clermont, Valerio Carelli, Valérie Biousse, Mark L. Moster, Robert C. Sergott, Thomas Klopstock...> ;International Ophthalmology Clinics. 2021 Oct 1
• 18 citations
  Long-Term Follow-Up After Unilateral Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy: The RESTORE Study.
  Valérie Biousse, N. J. Newman, Patrick Yu-Wai-Man, V. Carelli, Mark L. Moster, Catherine Vignal-Clermont, Thomas Klopstock, Alfredo A. Sadun, Robert C. Sergott, Rabih ...> ;Journal of Neuro-Ophthalmology. 2021 Sep 1
• 3 citations
  Lumbar Puncture for Diagnosis of Idiopathic Intracranial Hypertension in Typical Patients.
  Mathew Margolis, Adam A. DeBusk, Mark L. Moster, Julie Falardeau, Eric R. Eggenberger, Robert C. Sergott, Gregory P. Van Stavern> ;Journal of Neuro-Ophthalmology. 2021 Aug 4
• 4 citations
  Cross-Sectional Analysis of Baseline Visual Parameters in Subjects Recruited Into the RESCUE and REVERSE ND4-LHON Gene Therapy Studies.
  Mark L. Moster, Robert C. Sergott, N. J. Newman, Patrick Yu-Wai-Man, V. Carelli, Molly Scannell Bryan, Gerard Smits, Valérie Biousse, Catherine Vignal-Clermont, Thomas...> ;Journal of Neuro-Ophthalmology. 2021 Sep 1
• 34 citations
  Intravitreal Gene Therapy vs. Natural History in Patients With Leber Hereditary Optic Neuropathy Carrying the m.11778G>A ND4 Mutation: Systematic Review and Indirect C...
  Nancy J. Newman, Patrick Yu-Wai-Man, Valerio Carelli, Valérie Biousse, Mark L. Moster, Catherine Vignal-Clermont, Robert C. Sergott, Thomas Klopstock, Alfredo A. Sadun...> ;Frontiers in Neurology. 2021 May 24
• 85 citations
  APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies
  Aykut Aytulun, Andrés Cruz-Herranz, Orhan Aktas, Laura J. Balcer, Lisanne J. Balk, Piero Barboni, Augusto Azuara Blanco, Peter A. Calabresi, Fiona Costello, Bernardo S...> ;Neurology. 2021 Jul 13
• 5 citations
  Experience With Ventriculoperitoneal and Lumboperitoneal Shunting for the Treatment of Idiopathic Intracranial Hypertension: A Single Institution Series.
  Ahmad Sweid, Badih J Daou, Joshua H Weinberg, Robert M Starke, Robert C Sergott, Joseph Schaefer, Julie Hauge, Caroline Elizabeth, Nohra Chalouhi, Reid Gooch, Nabeel H...> ;Operative Neurosurgery. 2021 Jul 15
• 13 citations
  Visual evoked potential latency predicts cognitive function in people with multiple sclerosis.
  Thomas J. Covey, Daniel Golan, Glen M. Doniger, Robert C. Sergott, Myassar Zarif, Jared Srinivasan, Barbara Bumstead, Jeffrey Wilken, Marijean Buhse, Mark Gudesblatt> ;Journal of Neurology. 2021 Apr 18
• 72 citations
  Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset
  Nancy J. Newman, Patrick Yu-Wai-Man, Valerio Carelli, Mark L. Moster, Valérie Biousse, Catherine Vignal-Clermont, Robert C. Sergott, Thomas Klopstock, Alfredo A. Sadun...> ;Ophthalmology. 2021 Jan 12
• 18 citations
  Risdiplam treatment has not led to retinal toxicity in patients with spinal muscular atrophy
  Robert C. Sergott, Giulia Maria Amorelli, Giovanni Baranello, Emmanuel Barreau, Shannon Beres, Steven Kane, Eugenio Mercuri, Lorenzo Orazi, Melissa SantaMaria, Gemma T...> ;Annals of Clinical and Translational Neurology. 2021 Jan 1
• 7 citations
  Retinal Optical Coherence Tomography Metrics Are Unchanged in Verubecestat Alzheimer's Disease Clinical Trial but Correlate with Baseline Regional Brain Atrophy.
  Robert C. Sergott, Annaswamy Raji, James Kost, Cyrille Sur, Saheeda Jackson, Amy Locco, Arpankumar Patel, Christine Furtek, Britta A. Mattson, Michael F. Egan> ;Journal of Alzheimer's Disease. 2021 Jan 1
• 111 citations
  Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy
  Patrick Yu-Wai-Man, Nancy J. Newman, Valerio Carelli, Mark L. Moster, Valérie Biousse, Alfredo A. Sadun, Thomas Klopstock, Catherine Vignal-Clermont, Robert C. Sergott...> ;Science Translational Medicine. 2020 Dec 9
• 2 citations
  Papillitis with retinal venous congestion and intraocular inflammation.
  Connie M Wu, James P. Dunn, Robert C. Sergott> ;American Journal of Ophthalmology Case Reports. 2020 Sep 10
• 5 citations
  Atrial fibrillation post central retinal artery occlusion: Role of implantable loop recorders.
  Ryan A. Watson, Jennifer Wellings, Rittu Hingorani, Tingting Zhan, Daniel R. Frisch, Reginald T. Ho, Behzad B. Pavri, Robert C. Sergott, Arnold J. Greenspon> ;Pacing and Clinical Electrophysiology. 2020 Jun 21
• 3 citations
  Effect of Shunting on Visual Outcomes and Headache in Patients with Idiopathic Intracranial Hypertension.
  Badih J Daou, Ahmad Sweid, Joshua H. Weinberg, Robert M. Starke, Robert C. Sergott, Allison S. Doermann, Julie Hauge, Mario Zanaty, Nohra Chalouhi, Reid Gooch, Nabeel ...> ;World Neurosurgery. 2020 Oct 1
• 1 citations
  Change in visual acuity and retinal structures following Repository Corticotropin Injection (RCI) therapy in patients with acute demyelinating optic neuritis: Improvem...
  Molly Scannell Bryan, Robert C. Sergott> ;Journal of the Neurological Sciences. 2019 Dec 15
• 9 citations
  Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers
  Jessica Ackert, Khadeeja Mohamed, Jason S. Slakter, Sherif El-Harazi, Alessandro Berni, Hakop Gevorkyan, Elizabeth Hardaker, Azra Hussaini, Siôn W. Jones, Gavin C. K. ...> ;Drug Safety. 2019 Jun 11
• 16 citations
  Retrospective, Multicenter Comparison of the Clinical Presentation of Patients Presenting With Diplopia From Giant Cell Arteritis vs Other Causes.
  Ahmara G. Ross, Imran Jivraj, Geoffrey Rodriguez, Maxwell Pistilli, John J. Chen, Robert C. Sergott, Mark L. Moster, Claire A. Sheldon, Grant T. Liu, Rod Foroozan, Mel...> ;Journal of Neuro-Ophthalmology. 2019 Mar 1
• Join now to see all

Journal Articles

• ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis  
  Jeffrey L. Bennett, Peter Rieckmann, Xavier Montalbane, Daniel Mikol, Ulrich Freudensprung, Thomas Plitz, Johan van Beek, for the ATON Trial Group, Journal of Neurologic Science, 1/1/2015
• Segmental Analysis of Macular Layers in Patients with Unilateral Primary Open-Angle Glaucoma  
  Zangalli C, Ahmed O, Waisbourd M, et al, Journal of Glaucoma, 1/1/2015
• Simultaneous, bilateral ophthalmoplegia as the presenting sign of paediatric multiple sclerosis: Case report and discussion of the differential diagnosis  
  Adam MK, Krespan K, Moster ML, Neuro-Ophthalmology, 1/1/2014
• Vigabatrin-associated visual field loss: past, present and future  
  Sergott RC, Expert Rev. Ophthalmol, 1/1/2014
• Headaches associated with papilledema  
  Sergott RC, Curr Pain & Headache Reports, 1/1/2012
• Gilenya safety update: cardiac and macula, Editorial  
  with Huggins A, Curr Op Ophthalmol, 1/1/2012
• Understanding and interpreting vision safety issues with vigabatrin therapy  
  with Plant GT, Acta Neurologica Scandinavica, 1/1/2011
• Primer on visual field testing, electroretinography and other Visual field assessments for patient treated with vigabatrin  
  with Westall CA, Acta Neurologica Scandinavica, 1/1/2011
• Background and rationale for mechanism of action, efficacy, and Safety of fingolimod (Gilenya), the first oral therapy for remitting-relapsing multiple sclerosis: wit...  
  with Huggins A, Curr Op Ophthalmol, 1/1/2011
• Evidence-based review of recommendations for visual function testing in patients treated with Vigabatrin  
  Wheless JW, Smith MC, Westall CA, Kardon RH, Arnold A, Foroozan R, Sagar SM, Neuro-Ophthalmology, 1/1/2010
• Why OCT in Neuro-ophthalmology?  
  Sergott RC, J Ophthalmic Photog, 1/1/2010
• Vigabratrin-induced peripheral visual field defects in patients with refractory partial epilepsy  
  Bittman RM, Christen EM, Sagar SM, Epilepsy Res, 1/1/2010
• Disease duration-dependent retinal nerve fiber layer loss in untreated multiple sclerosis: The natural history of retinal axonal degeneration in multiple sclerosis  
  Spain RI, Maltenfort M, Leist TP, J Rehabil Res & Dev, 1/1/2009
• Clinical Manifestations and treatment of adult-onset asthma and periocular xanthogranuloma  
  Cavallazzi R, Hirani A, Vasu TS, Bilyk JR, Eagle RC, Weibel S, Can Respir J, 1/1/2009
• Modeling axonal degeneration within the anterior visual system: Implications for demonstrating neuroprotection in Multiple Sclerosis  
  Frohman EM, Costello F, Stuve O, Calabresi P, Miller DH, Hickman SJ, Conger A, Salter A, Krumwiede KH, Frohman TC, Balcer L, Zivadinov R, Arch Neurol, 1/1/2008
• The role of optical coherence Tomography in multiple sclerosis: expert panel consensus  
  Frohman E, Glanzman R, Al-Sabbagh A, J Neurol Sci, 1/1/2007
• New directions in optic neuritis and multiple sclerosis  
  with Gilbert ME, Current Neurology & Neuroscience Repts, 1/1/2007
• Anterior ischemic optic neuropathy after rotator cuff surgery  
  Gilbert ME, Savino PJ, Br J Ophthalmol, 1/1/2006
• Intracranial aneurysms  
  with Gilbert ME, Curr Op Ophthalmol, 1/1/2006
• Pathological optic-disc cupping  
  with Piette SD, Curr Op Ophthalmol, 1/1/2006
• Fractionated stereoactic radiotherapy for parasellar meningiomas: a preliminary report of visual outcomes  
  Behbehani RS, McElveen T, Savino PJ, Br J Ophthalmol, 1/1/2005
• Foggy Vision  
  Behbehani R, Frohman L, Surv. Ophthalmol, 1/1/2005
• Multifocal ERG in ethambutol associated visual loss  
  Behbehani RS, Affel EL, Savino PJ, Br J Ophthalmol, 1/1/2005
• Tobacco-alcohol amblyopia: a maculopathy?  
  Behbehani R, Savino PJ, Br J Ophthalmol, 1/1/2005
• Visual function more than 10 years after optic neuritis: Experience of the optic neuritis treatment trial  
  Optic Neuritis Study Group, A J Ophthalmol, 1/1/2004
• Join now to see all

Books/Book Chapters

• Medical Imaging in Clinical Trials 
  Chapter: Chapter 13: Optical Coherence Tomography in Clinical Trials for Ophthalmology and Neurology 
  Page 277 - 291Sergott RCEditors: Miller CG, Krasnow J and Schwartz LH.Springer2014
• Craniopharyngiomas 
  Chapter: Chapter 6: Neuro-ophthalmic Manifestations of Craniopharyngiomas 
  Sergott RCEditors: Kenning and Evana.Springer2014
• International Ophthalmology Clinics 
  Chapter: Historical perspective and future prospective for retinal nerve fiber layer loss in optic neuritis and multiple sclerosis 
  Page 15 - 24Sergott RCEditors: Foroozan R.Lippincott Williams & Wilkins, Philadelphia, PA2007
• Year Book of Ophthalmology 
  Chapter: Can the Internet save neuro-ophthalmology and ophthalmology? Silicon Valley meets the Ether Dome 
  Page 207 - 210Sergott RCEditors: Wilson RP.Mosby Yearbook, St. Louis, MO2001
• Year Book of Ophthalmology 
  Chapter: Tele-neuro-ophthalmology: Economical Access to Quality Care 
  Page 247 - 249with Williams CAEditors: Wilson RP.Mosby Yearbook, St. Louis, MO1997
• Ocular Infection & Immunity 
  Chapter: Multiple Sclerosis 
  Page 694 - 722Beck RW, Lisak RP, Arnold ACEditors: Pepose JS, Holland GN, Wilhelmus KR.Mosby Year Book, Inc., St. Louis, MO1996
• Handbook of Myasthenia Gravis and Myasthenic Syndromes 
  Chapter: Ocular Myasthenia 
  Page 21 - 31Sergott RCEditors: Lisak RP.Marcel Dekker, Inc., New York, NY1994
•  
  Chapter: Optic Nerve Sheath Decompression 
  Page 395 - 404with Flaharty PMW.B. Saunders Company, Philadelphia, PA1992
• International Ophthalmology Clinics 
  Chapter: Optic Nerve Sheath Decompression: A Review 
  Page 179 - 196with Maus MEditors: Shore JW.Little, Brown and Company, Boston, MA1992
• International Ophthalmology Clinics 
  Chapter: Optic Nerve Sheath Decompression: History, Techniques, and Indications 
  Page 71 - 81Sergott RCLittle,Brown and Company, Boston MA1991
• The Eye and Systemic Diseases 
  Sergott RCEditors: Gold and Weingeist.J.B. Lippincott Co1990
• Current Opinion in Ophthalmology 
  Chapter: Thyroid eye disease 
  Page 187 - 189Sergott RCEditors: G.W. Weinstein.1990
• Current Therapy in Ophthalmic Surgery 
  Chapter: Optic Nerve Sheath Decompression 
  Page 302 - 306Sergott RCEditors: Spaeth GL, Katz LJ.B.C. Decker, Inc., Toronto1989
• The Yearbook of Ophthalmology 
  Page 67 - 68Sergott RCEditors: Laibson PR.Yearbook Medical Publishers, Inc.1989
• Join now to see all

Abstracts/Posters

• Segmental Analysis of Macular Layers in Patients with Unilateral Primary Open-Angle Glaucoma
  Sergott RC, Association for Research in Vision and Ophthalmology Meeting, Denver, 1/3/2015
• Monitoring of Alzheimer's Disease with Retina Examination
  with Umar A. Kayabasi, M.D., NANOS, 1/1/2015
• Retinal Ganglion Cell & Inner Plexiform Layer Loss Correlate with Visual Acuity Loss in LHON: A High-Resolution, Longitudinal, Segmentation OCT Analysis
  Stephen J. Moster, MD, Mark L. Moster, MD, American Association of Neurology, Philadelphia, 1/1/2015
• The Sabril Registry After 5 Years: Patient Characteristics and Vision Loss
  R Foroozan, E Faught, et al, American Association of Neurology, Philadelphia, 1/1/2015
• Lebers hereditary optic neuropathy & untreated remitting relapsing MS share multicolor OCT findings: potential biomarker for mitochondrial flavoprotein biosynthesis an...
  with M.L. Moster, ECTRIMS, Barcelona Spain, 1/1/2015
• The Sabril Registry After 5 Years: Patient Characteristics and Vision Loss
  Sergott RC, American Epilepsy Society Meeting, Seattle WA, 1/7/2014
• Multi-color Laser Retinal Imaging Displays Outer Retinal and Retinal Vascular Changes in Alzheimer Patients
  with U Kayabasi, Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART), Copenhagen, 1/1/2014
• OCT Imaging in Neuro-Ophthalmology and Glaucoma
  Sergott RC, Imaging Summit, Cole Eye, Cleveland Clinic, San Diego, 1/1/2014
• MultiColor Retinal Imaging in Acute Optic Neuritis: A New Potential Biomarker for Multiple Sclerosis
  ML Moster, E Affel, ECTRIMS, Boston, 1/1/2014
• Retrospective Correlation of mfERG and SD-OCT between RRMS and PPMS Patients with and without Optic Neuritis
  AM Flowers, MK Adam, ECTRIMS, Boston, 1/1/2014
• Correlation of Macular and Retinal Nerve Fiber Layer (RNFL) Parameters with Disease Duration in Untreated MS
  Spain RI, Leist TP, Ann Neurol, 1/1/2007
• Subgroup Analyses of Retinal Nerve Fiber Layer Thickness Changes in Patients with Multiple Sclerosis and Optic Neuritis Concurrent with High-Dose, High-Frequency Inter...
  Sergott RC, 32nd Annual North American Neuro-Ophthalmology Society (NANOS) Meeting, Tucson, AZ, 1/25/2006
• In Vivo Neuroprotection with High Dose, High-Frequency Interferon Therapy: A Serial Optical Coherence Tomography Study in Multiple Sclerosis and Optic Neuritis
  Sergott RC, 21st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and 10th Annual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Meeting, Thessaloniki, Greece, 1/28/2005
• Paradoxical Worsening of Dural-Cavernous Sinus Fistulas Revisited - Application of Color Doppler Imaging
  Sergott RC, American Academy of Ophthalmology, Annual Meeting, San Francisco, CA, 1/30/1994
• Diabetic papillopathy: Clinical Characteristics and outcome
  Regillo CD, Brown GC, Savino PJ, Byrnes GA, Benson WE, Tasman WS, American Academy of Ophthalmology, 1/1/1994
• Kay MD, Savino PJ, Best SJ, 1/1/1993
• Oculomotor Paresis and Ocular Ischemia in Giant Cell Arteritis
  Sergott RC, American Academy of Ophthalmology, Annual Meeting, Anaheim, CA, 1/13/1991
• Color Doppler Imaging of the Ocular Ischemic Syndrome
  Sergott RC, American Academy of Ophthalmology, Annual Meeting, Anaheim, CA, 1/13/1991
• Color Doppler imaging of the ocular ischemic syndrome
  Ho AC, Lieb WE, Flaharty PM, Brown GC, Bosley TM, Savino PJ, American Academy of Ophthalmology, 1/1/1991
• Vascular resistance patterns in normals and central retinal vein occlusion
  Lieb WE, Flaharty PM, Ho AC, Brown GC, Bosley TM, Savino PJ, American Academy of Ophthalmology, 1/1/1991
• Flaharty PM, Bosley TM, Savino PJ, American Academy of Ophthalmology, 1/1/1991
• Sergott RC, American Academy of Ophthalmology, Annual Meeting, Atlanta, GA, 1/28/1990
• Optic Neuritis Treatment Trial (ONTT): Initial Visual Field Defects
  Sergott RC, American Academy of Ophthalmology, Annual Meeting, Atlanta, GA, 1/28/1990
• Effect of Optic Nerve Damage on Human Cerebral Glucose Metabolism: Positron Emission Tomography
  Sergott RC, American Academy of Ophthalmology, Annual Meeting, New Orleans, LA, 1/29/1989
• Keltner JL, Thirkill CE, Fitzgerald P, and Roth AM, Invest Ophthalmol and Vis Science Suppl, 1/1/1987
• Join now to see all

Lectures

• Green Retinas and Mitochondria: MultiColor OCT Illuminates Leber’s Hereditary Optic Neuropathy, MS, Alzheimer’s Parkinson’s, Glaucoma and Vitreo-Macular Traction 
  1/13/2015
• Found in Translation: What the Retina and OCT Are Telling Us About MS, Parkinson’s, and Alzheimer’s 
  Temple University, Philadelphia PA - 1/1/2015
• Retina Examination with Examination with Curcumin for the Diagnosis of Alzheimer’s Disease 
  Istanbul, Turkey - 1/12/2014
• Optical Coherence Tomography in Multiple Sclerosis and Neurodegeneration 
  Department of Ophthalmology, Downstate Medical Center, Buffalo, NY - 1/31/2013
• Optical Coherence Tomography in Glaucoma and Neuro-Ophthalmology, Liking the Retina, Optic Nerve and Brain 
  Toronto, Canada - 1/30/2013
• Tele-Medicine for Diabetic Retinopathy 
  Thomas Jefferson Medical Center, Department Medicine - 1/29/2013
• Hierarchy of Neurodegeneration of MS and Optic Neuritis 
  Novartis Pharmaceutical - 1/27/2013
• Traumatic Brain Injury, Traumatic Maculopathy and Optic Neuritis 
  US Department of Defense, Center for Vision Excellence, Spokane, WA - 1/25/2013
• Optical Coherence Tomography in Neuro-Ophthalmology 
  Donyaguzi Hospital, Department of Ophthalmology, Istanbul, Turkey, 2012; Hahnemann/ Drexel Universit - 1/18/2013
• Temporal Arteritis 
  Hahnemann/ Drexel University Medical Center, Department of Rheumatology, Philadelphia PA - 1/16/2013
• Optical Coherence Tomography, MERG, MVEP: A Triad for Regulatory Approval for Neurodegeneration 
  1/1/2013
• OCT Plus in Neuro-Ophthalmology, Multiple Sclerosis, Alzheimer’s, Parkinson’s, and Traumatic Brain Injury 
  1/1/2013
• Optic Neuritis and Multifocal ERG and Optical Coherence Tomography 
  London, England - 1/1/2012
• Optical Coherence Tomography in Alzheimer’s, Parkinson’s and Other Neurodegenerative diseases 
  London, England - 1/1/2012
• Optical Coherence Tomography in Neuro-Degeneration: MS, Alzheimer’s and Parkinson’s Disease – as part of the 50th Anniversary 
  Bascom-Palmer Eye Institute - 1/1/2012
• Trauma to the Optic Nerve and Retina – What it Teaches Us About Cataract Surgery Complications 
  Philadelphia, PA - 1/1/2012
• Trauma to Optic Nerve and Retina 
  1/1/2012
• The Ophthalmologist’s Responsibility for Monitoring Fingolimod – The First Oral Medication for Multiple Sclerosis 
  Philadelphia, PA - 1/1/2011
• Optical Coherence Tomography in Neuro-Ophthalmology: The First Five Years and the Future 
  University of Illinois, Chicago - 1/26/2009
• Transient Visual Loss: A Practical Approach 
  University of Florida Department of Ophthalmology, Tampa, FL - 1/17/2008
• You Don’t Need A Weatherman to Know Which Way the Wind Blows 
  University of Florida Department of Ophthalmology, Tampa, FL - 1/17/2008
• Returns from the Outlying Precincts--What OCT, the Macula and the Retina are Telling Us About Multiple Sclerosis and Optic Neuritis 
  Greater Baltimore Medical Center, Baltimore, MD - 1/14/2008
• When Optic Nerve Pallor Is Not Glaucoma 
  Atlantic City, NJ - 1/11/2008
• Optical Coherence Tomography in MS and Optic Neuritis: In Vivo Biomarker of Neuroprotection 
  Virginia Commonweath University, Richmond, VA - 1/25/2007
• High-Dose, High-Frequency Interferon Therapy in RRMS 
  Howard University Hospital, Washington, DC - 1/16/2007
• Join now to see all